Abstract Listings 2024

Successful Treatment for Facial Hemangioma using Sclerotherapy with Bleomycin: Experience from Tertiary Hospital in Indonesia

Author: Anindita Wicitra
Base Hospital / Institution: Dharmais National Cancer Center

ePoster presentation

Abstract ID: 24-433

Purpose

Hemangioma is a common type of benign vascular tumor that usually affects newborns and infants. The incidence of eyelid and orbit hemangiomas is 10% of all hemangiomas. The purpose of this study is to describe successful results for facial hemangioma using sclerotherapy.


Methods

A case report


Results

A 9-month-old girl came with chief complaint of reddish mass in her left eye since she was 3 days old. Her mass became bigger over time from the size of a coin and increased in size extending into her cheek. There was history of spontaneous bleeding once when she was 3 months old. She was given propranolol from her previous pediatrician but her mother did not continue due to complaint of weakness. Ophthalmology examination revealed strawberry-liked mass covering her left eye palpebra extending into maxilla and temporal region. Anterior and posterior segments were within normal limits. Orbital MRI showed a solid mass suggestive of vascular lesion with feeding artery from left external carotid artery branches, size 7.5 x 6.3 x 9.1 cm in left maxilla- buccal – mandible region, extending into left orbit, ocular bulb, rectus muscles, optic nerve, and attached to frontal bone, temporal bone, and parietal bone. We diagnosed her with giant infantile hemangioma and consulted to our interventional radiologist. She underwent five times trans arterial sclerotherapy using bleomycin 7.5mg in 15cc. Satisfactory results showed after five times of sclerosing therapy. Her mass decreased to 3x5cm in inferior palpebra of her left eye. Mass became thinned in maxilla and temporal region.


Conclusion

Treatment of hemangiomas depends on its location and whether the lesion leads to visual impairment. Sclerotherapy acts by blocking hemangioma growth by targeting their vascularity accelerating their regression.


Additional Authors

First name Last name Base Hospital / Institution
Rio Hermawan Dharmais National Cancer Center
Haridini Mahdi Dharmais National Cancer Center

↑ Back to top